Cervical Cancer Detection Using Optical Spectroscopy
| Status: | Recruiting |
|---|---|
| Conditions: | Cervical Cancer, Cancer, Women's Studies |
| Therapuetic Areas: | Oncology, Reproductive |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/28/2018 |
| Start Date: | May 2006 |
| End Date: | June 2020 |
| Contact: | Nimmi Ramanujam, Ph.D. |
| Email: | nimmi@duke.edu |
| Phone: | 919-660-5307 |
The objective of the work described in this protocol is to determine the optical signatures
of cervical dysplasia using optical technologies.
of cervical dysplasia using optical technologies.
Inclusion Criteria:
- undergoing colposcopy for the diagnosis of cervical cancer
- LEEP for the treatment of cervical cancer in early stages.
Exclusion Criteria:
- Women under the age of 18 (minors) will be excluded from this study.
- patients will be excluded if she has had a recent episode of bleeding or preterm
labor.
- Subjects who are not competent to give consent will excluded
We found this trial at
1
site
2301 Erwin Rd
Durham, North Carolina 27710
Durham, North Carolina 27710
919-684-8111
Principal Investigator: Nimmi Ramanujam, Ph.D.
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
Click here to add this to my saved trials
